Saltz, Leonard B.

Publications

Sort by

Co-Author Network

selected publications

Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative. European journal of cancer (Oxford, England : 1990). 2020 Academic Article GET IT
Times cited: 12
A rectal cancer organoid platform to study individual responses to chemoradiation. Nature medicine. 2019 Academic Article GET IT
Times cited: 239
Molecular and cytogenetic characteristics of myeloid malignancies following luminal gastrointestinal cancer. Leukemia research. 2019 Academic Article GET IT
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy. JAMA oncology. 2019 Academic Article GET IT
Times cited: 270
Precision oncology giveth and precision oncology taketh away. The Lancet. Oncology. 2019 Comment GET IT
Times cited: 2
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions. Cancer research. 2019 Academic Article GET IT
Times cited: 95
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Academic Article GET IT
Times cited: 290
Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 276
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 221
Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma. Journal of the National Comprehensive Cancer Network : JNCCN. 2018 Academic Article GET IT
Times cited: 35
The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer. Annals of surgical oncology. 2017 Academic Article GET IT
Times cited: 62
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing. JAMA. 2017 Academic Article GET IT
Times cited: 289
Commentary: Somatostatin analogs-How we choose, and why. Seminars in oncology. 2017 Academic Article GET IT
Times cited: 1
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Academic Article GET IT
Times cited: 137
Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma. The oncologist. 2017 Academic Article GET IT
Times cited: 15
An elderly man with remote history of metastatic melanoma now with localized pancreas cancer and new liver masses. 2017 GET IT
Times cited: 5357
MicroRNA-203 predicts human survival after resection of colorectal liver metastasis. Oncotarget. 2017 Academic Article GET IT
Times cited: 16
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. 2017 GET IT
Times cited: 536
Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival. Molecular cancer research : MCR. 2017 Academic Article GET IT
Times cited: 16
Clinical and genetic determinants of ovarian metastases from colorectal cancer. Cancer. 2016 Academic Article GET IT
Times cited: 36
A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803. The oncologist. 2016 Academic Article GET IT
Times cited: 11
Reply to G. Le Flahec et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Letter GET IT
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. The Lancet. Oncology. 2016 Academic Article GET IT
Times cited: 356
Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database. Journal of geriatric oncology. 2016 Academic Article GET IT
Times cited: 8
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 463
Faster FOLFOX: Oxaliplatin Can Be Safely Infused at a Rate of 1 mg/m2/min. Journal of oncology practice. 2016 Academic Article GET IT
Times cited: 4
Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 175
Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters. European radiology. 2016 Academic Article GET IT
Times cited: 53
Genetic Screening in All Young Patients With Colorectal Cancer?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Letter GET IT
Times cited: 3
Overspending driven by oversized single dose vials of cancer drugs. BMJ (Clinical research ed.). 2016 Academic Article GET IT
Times cited: 99
A Phase II Efficacy and Safety, Open-Label, Multicenter Study of Imprime PGG Injection in Combination With Cetuximab in Patients With Stage IV KRAS-Mutant Colorectal Cancer. Clinical colorectal cancer. 2016 Academic Article GET IT
Times cited: 28
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Review GET IT
Times cited: 23
PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis. The Journal of clinical investigation. 2016 Academic Article GET IT
Times cited: 51
Perspectives on Cost and Value in Cancer Care. JAMA oncology. 2016 Editorial Article GET IT
Times cited: 42
Value in Colorectal Cancer Treatment: Where It Is Lacking, and Why. Cancer journal (Sudbury, Mass.). 2016 Review GET IT
Times cited: 9
The Value of Considering Cost, and the Cost of Not Considering Value. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Academic Article GET IT
Times cited: 21
Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAF. Molecular cancer research : MCR. 2015 Academic Article GET IT
Times cited: 37
Erratum to: Lymph Node Metastasis Predicts Disease Recurrence in a Single-Center Experience of 70 Stages 1-3 Appendix Cancers: A Retrospective Review. Annals of surgical oncology. 2015 Article GET IT
Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Review GET IT
Times cited: 98
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Academic Article GET IT
Times cited: 483
Identification of germline genetic mutations in patients with pancreatic cancer. Cancer. 2015 Academic Article GET IT
Times cited: 145
Reply to A. Messori et al, R. Bordonaro et al, and G. Fasola et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Letter GET IT
Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Academic Article GET IT
Times cited: 50
Phase 1 study of APTO-253 HCl, an inducer of KLF4, in patients with advanced or metastatic solid tumors. Investigational new drugs. 2015 Academic Article GET IT
Times cited: 31
Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI. Annals of surgical oncology. 2015 Editorial Article GET IT
Times cited: 7
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. 2015 GET IT
Times cited: 707
Liver-directed conversion therapy in metastatic colon cancer. Journal of gastrointestinal oncology. 2015 Academic Article GET IT
Times cited: 2
Rectal Cancer, Version 2.2015. Journal of the National Comprehensive Cancer Network : JNCCN. 2015 Academic Article GET IT
Times cited: 169
RAF plus EGFR Inhibition for BRAF-Mutant Metastatic Colorectal Cancer-Response. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Letter GET IT
Times cited: 1
The Cost and Value of Anti-Epidermal Growth Factor Receptor Therapies: Let's Not Be Rash. JAMA oncology. 2015 Academic Article GET IT
Times cited: 3
Primary tumor location as a prognostic factor in metastatic colorectal cancer. Journal of the National Cancer Institute. 2015 Academic Article GET IT
Times cited: 223
Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†. Annals of oncology : official journal of the European Society for Medical Oncology. 2015 Review GET IT
Times cited: 11
Can money really be no object when cancer care is the subject?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Editorial Article GET IT
Times cited: 22
Lymph Node Metastasis Predicts Disease Recurrence in a Single-Center Experience of 70 Stages 1-3 Appendix Cancers: A Retrospective Review. Annals of surgical oncology. 2015 Academic Article GET IT
Times cited: 18
Serum 25-hydroxy vitamin D and survival in advanced colorectal cancer: a retrospective analysis. Nutrition and cancer. 2015 Academic Article GET IT
Times cited: 39
Colorectal cancer. Hematology/oncology clinics of North America. 2015 Editorial Article GET IT
Times cited: 3
Extracellular metabolic energetics can promote cancer progression. Cell. 2015 Academic Article GET IT
Times cited: 251
Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Academic Article GET IT
Times cited: 213
Hospitalists on an inpatient tertiary care oncology teaching service. Journal of oncology practice. 2015 Academic Article GET IT
Times cited: 6
Neuroendocrine tumors, version 1.2015. 2015 GET IT
Times cited: 270
30-day-or-sooner readmissions of gastrointestinal medical oncology patients following cancer center inpatient service discharge: characteristics and preventability. Hospital practice (1995). 2014 Academic Article GET IT
Times cited: 8
Aspirin and COX-2 inhibitor use in patients with stage III colon cancer. Journal of the National Cancer Institute. 2014 Academic Article GET IT
Times cited: 114
Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 87
ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer. Journal of the National Cancer Institute. 2014 Academic Article GET IT
Times cited: 52
MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trial. PloS one. 2014 Academic Article GET IT
Times cited: 17
Management of metastatic colorectal cancer. Oncology (Williston Park, N.Y.). 2014 Academic Article GET IT
Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment. Journal of the National Cancer Institute. 2014 Academic Article GET IT
Times cited: 165
Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer. Clinical colorectal cancer. 2014 Academic Article GET IT
Times cited: 30
Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 93
Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions. Genome biology. 2014 Academic Article GET IT
Times cited: 259
Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
Times cited: 47
Colon cancer, version 3.2014. 2014 GET IT
Times cited: 193
Occult primary, version 3.2014. 2014 GET IT
Times cited: 23
Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance). PloS one. 2014 Academic Article GET IT
Times cited: 60
Colorectal cancer survivors' needs and preferences for survivorship information. Journal of oncology practice. 2014 Academic Article GET IT
Times cited: 23
False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2014 Academic Article GET IT
Times cited: 70
CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer. Gastroenterology. 2014 Academic Article GET IT
Times cited: 102
BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer. Cancer. 2014 Academic Article GET IT
Times cited: 146
Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2014 Academic Article GET IT
Times cited: 149
Hospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802). Journal of geriatric oncology. 2014 Academic Article GET IT
Times cited: 3
Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 336
Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial. Journal of the National Cancer Institute. 2013 Academic Article GET IT
Times cited: 41
Colorectal cancer patients with oligometastatic liver disease: what is the optimal approach?. Oncology (Williston Park, N.Y.). 2013 Academic Article GET IT
Times cited: 41
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial. Cancer. 2013 Academic Article GET IT
Times cited: 48
A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma. Journal of hepatology. 2013 Academic Article GET IT
Times cited: 75
Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/Alliance. Clinical colorectal cancer. 2013 Academic Article GET IT
Times cited: 32
Frequency, characteristics, and correlates of pain in a pilot study of colorectal cancer survivors 1-10 years post-treatment. Pain medicine (Malden, Mass.). 2013 Academic Article GET IT
Times cited: 15
Study using the NCCN guidelines for palliative care to screen patients for palliative care needs and referral to palliative care specialists. Journal of the National Comprehensive Cancer Network : JNCCN. 2013 Academic Article GET IT
Times cited: 36
Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013 Academic Article GET IT
Times cited: 35
Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study. Annals of surgery. 2013 Academic Article GET IT
Times cited: 90
A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas. British journal of cancer. 2013 Academic Article GET IT
Times cited: 99
Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer. Clinical colorectal cancer. 2013 Academic Article GET IT
Times cited: 24
Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Academic Article GET IT
Times cited: 180
Role of expression profiling in carcinoma of unknown primary remains unknown. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Letter GET IT
Times cited: 4
Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2013 Academic Article GET IT
Times cited: 37
A 40-year-old woman with locally advanced rectal cancer and a solitary liver metastasis. Gastrointestinal cancer research : GCR. 2013 Academic Article GET IT
Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. 2013 GET IT
Times cited: 63
Systemic therapy for metastatic colorectal cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2013 Review GET IT
Times cited: 8
Management of a patient diagnosed with pancreatic cancer and myelodysplastic syndrome. Gastrointestinal cancer research : GCR. 2013 Academic Article GET IT
Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network : JNCCN. 2013 Academic Article GET IT
Times cited: 141
Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405. Clinical colorectal cancer. 2013 Academic Article GET IT
Times cited: 16
Biologic agents in the treatment of colorectal cancer: the last decade; the lost decade?. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2013 Review GET IT
Times cited: 1
Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Annals of surgery. 2012 Academic Article GET IT
Times cited: 288
Rectal cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2012 Academic Article GET IT
Times cited: 129
Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. Journal of the National Cancer Institute. 2012 Academic Article GET IT
Times cited: 137
BRAF mutations in colorectal cancer: clinical relevance and role in targeted therapy. Journal of the National Comprehensive Cancer Network : JNCCN. 2012 Academic Article GET IT
Times cited: 11
Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1 H MRS study. NMR in biomedicine. 2012 Academic Article GET IT
Times cited: 8
Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma. Gastrointestinal cancer research : GCR. 2012 Academic Article GET IT
Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective study. Annals of surgery. 2012 Academic Article GET IT
Times cited: 53
Comparative genomic analysis of primary versus metastatic colorectal carcinomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 225
Neuroendocrine tumors. 2012 GET IT
Times cited: 147
Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer. Cancer. 2012 Academic Article GET IT
Times cited: 27
Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature. Human pathology. 2012 Review GET IT
Times cited: 79
Antitumor activity in metastatic disease does not predict efficacy in the adjuvant setting. JAMA. 2012 Editorial Article GET IT
Times cited: 3
Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome. Annals of surgical oncology. 2012 Academic Article GET IT
Times cited: 54
Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines. 2012 GET IT
Times cited: 64
FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation. Diseases of the colon and rectum. 2012 Academic Article GET IT
Times cited: 23
A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors. Cancer. 2012 Academic Article GET IT
Times cited: 55
Factors dictating outcomes in patients with colorectal cancer and peritoneal carcinomatosis: selection, resection, or convection?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Editorial Article GET IT
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Academic Article GET IT
Times cited: 231
NCCN Clinical Practice Guidelines Occult primary. 2011 GET IT
Times cited: 28
Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. European radiology. 2011 Academic Article GET IT
Times cited: 121
Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer. Clinical colorectal cancer. 2011 Academic Article GET IT
Times cited: 60
Colon cancer. 2011 GET IT
Times cited: 37
Palliative care in the outpatient oncology setting: evaluation of a practical set of referral criteria. Journal of oncology practice. 2011 Academic Article GET IT
Times cited: 57
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials. Journal of the National Cancer Institute. 2011 Review GET IT
Times cited: 51
Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors. Oncology. 2011 Academic Article GET IT
Times cited: 7
Surgery and high-dose-rate intraoperative radiation therapy for recurrent squamous-cell carcinoma of the anal canal. Diseases of the colon and rectum. 2011 Academic Article GET IT
Times cited: 25
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803. Journal of the National Cancer Institute. 2011 Academic Article GET IT
Times cited: 65
Doxorubicin and sorafenib for treatment of advanced hepatocellular cancer. Gastroenterology. 2011 Letter GET IT
Times cited: 6
Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Academic Article GET IT
Times cited: 146
KRAS and colorectal cancer: ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practice. The oncologist. 2011 Academic Article GET IT
Times cited: 16
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results. British journal of cancer. 2011 Academic Article GET IT
Times cited: 191
BEYOND KRAS: Other markers and potential treatment strategies for KRAS mutant and wild-type patients. Current treatment options in oncology. 2011 Academic Article GET IT
Times cited: 2
Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision. Annals of surgical oncology. 2011 Academic Article GET IT
Times cited: 36
Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis. Annals of surgical oncology. 2011 Academic Article GET IT
Times cited: 30
Venous thromboembolic events with chemotherapy plus bevacizumab: a pooled analysis of patients in randomized phase II and III studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Review GET IT
Times cited: 176
Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients. Annals of oncology : official journal of the European Society for Medical Oncology. 2011 Review GET IT
Times cited: 74
Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803. European journal of cancer (Oxford, England : 1990). 2011 Review GET IT
Times cited: 100
Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase III trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 144
Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial. JAMA. 2010 Academic Article GET IT
Times cited: 379
Addition of octreotide functional imaging to cross-sectional computed tomography or magnetic resonance imaging for the detection of neuroendocrine tumors: added value or an anachronism?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Letter GET IT
Times cited: 19
Adjuvant therapy for colon cancer. Surgical oncology clinics of North America. 2010 Review GET IT
Times cited: 23
Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study). Anticancer research. 2010 Academic Article GET IT
Times cited: 37
Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 34
Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 121
Genomic and biological characterization of exon 4 KRAS mutations in human cancer. Cancer research. 2010 Academic Article GET IT
Times cited: 229
Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 242
Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning. International journal of radiation oncology, biology, physics. 2010 Academic Article GET IT
Times cited: 69
Evolving treatment of advanced colorectal cancer. Current oncology reports. 2010 Review GET IT
Times cited: 16
Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803. Cancer. 2010 Academic Article GET IT
Times cited: 54
ACR Appropriateness Criteria: local excision in early-stage rectal cancer. Current problems in cancer. 2010 Review GET IT
Times cited: 11
ACR Appropriateness Criteria: rectal cancer-metastatic disease at presentation. Current problems in cancer. 2010 Review GET IT
Times cited: 10
NCCN clinical practice guidelines in oncology. Anal carcinoma. 2010 GET IT
Times cited: 44
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 177
Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies. Journal of cancer research and clinical oncology. 2009 Academic Article GET IT
Times cited: 137
Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial. British journal of cancer. 2009 Academic Article GET IT
Times cited: 146
NCCN Clinical Practice Guidelines in Oncology: colon cancer. 2009 GET IT
Times cited: 301
NCCN Clinical Practice Guidelines in Oncology: rectal cancer. 2009 GET IT
Times cited: 212
A prospective randomized trial of topical pimecrolimus for cetuximab-associated acnelike eruption. Journal of the American Academy of Dermatology. 2009 Academic Article GET IT
Times cited: 59
Apples and oranges: the low and mid versus the upper rectum. Nature reviews. Clinical oncology. 2009 Article GET IT
NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors. 2009 GET IT
Times cited: 111
Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 328
Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. The Annals of thoracic surgery. 2009 Academic Article GET IT
Times cited: 161
NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2009 Review GET IT
Times cited: 102
Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors. Cancer investigation. 2009 Academic Article GET IT
Times cited: 1
p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 14
Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 318
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Review GET IT
Times cited: 144
Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors. Nature clinical practice. Oncology. 2009 Review GET IT
Times cited: 27
Evolving treatment of advanced colon cancer. Annual review of medicine. 2009 Review GET IT
Times cited: 110
First-line treatment of patients with metastatic colorectal cancer: an overview of recent data on chemotherapy plus targeted agents. Clinical colorectal cancer. 2008 Review GET IT
Times cited: 7
Occult primary. Journal of the National Comprehensive Cancer Network : JNCCN. 2008 Review GET IT
Times cited: 3
Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer. Investigational new drugs. 2008 Academic Article GET IT
Times cited: 4
Progress in cancer care: the hope, the hype, and the gap between reality and perception. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 30
Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 200
Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer. 2008 Academic Article GET IT
Times cited: 219
Association of family history with cancer recurrence and survival among patients with stage III colon cancer. JAMA. 2008 Academic Article GET IT
Times cited: 69
Biomarkers in colorectal cancer: added value or just added expense?. Expert review of molecular diagnostics. 2008 Editorial Article GET IT
Times cited: 5
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?. The American journal of surgical pathology. 2008 Academic Article GET IT
Times cited: 144
Potential regional differences for the tolerability profiles of fluoropyrimidines. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 207
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 2581
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 750
ACR Appropriateness Criteria on resectable rectal cancer: expert panel on radiation oncology--rectal/anal cancer. 2008 GET IT
Times cited: 6
Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Review GET IT
Times cited: 201
NCCN Task Force Report: Oral chemotherapy. Journal of the National Comprehensive Cancer Network : JNCCN. 2008 Review GET IT
Times cited: 347
Systemic therapy for colon cancer. Gastroenterology clinics of North America. 2008 Review GET IT
Times cited: 19
Bevacizumab: one treatment for all the seasons?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Letter GET IT
Times cited: 1
Individualized prediction of colon cancer recurrence using a nomogram. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 226
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 251
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 139
The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor. Investigational new drugs. 2007 Academic Article GET IT
Times cited: 208
Colon cancer. 2007 GET IT
Times cited: 9
Rectal cancer. 2007 GET IT
Times cited: 8
Targeted strategies in the treatment of metastatic colon cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2007 Review GET IT
Times cited: 5
A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Academic Article GET IT
Times cited: 74
Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 379
End points in advanced colon cancer clinical trials: a review and proposal. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Comment GET IT
Times cited: 63
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA. 2007 Academic Article GET IT
Times cited: 331
Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 383
ACR Appropriateness Criteria on treatment of anal cancer. 2007 GET IT
Bevacizumab 5 mg/kg can be infused safely over 10 minutes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 54
Size matters. What can we learn from a small randomized trial?. Onkologie. 2007 Editorial Article GET IT
Adjuvant therapy of colon cancer: current status and future directions. Cancer journal (Sudbury, Mass.). 2007 Review GET IT
Times cited: 55
Panitumumab. Nature reviews. Drug discovery. 2006 Article GET IT
Times cited: 56
Planned treatment interruptions and chemotherapy-free intervals in the treatment of metastatic colorectal cancer: time to start stopping?. Seminars in oncology. 2006 Review GET IT
Times cited: 5
Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study. Annals of surgical oncology. 2006 Academic Article GET IT
Times cited: 157
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 1111
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 588
New issues on cetuximab mechanism of action in epidermal growth factor receptor-negative colorectal cancer: the role of vascular endothelial growth factor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Letter GET IT
Times cited: 33
Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa. Cancer. 2006 Academic Article GET IT
Times cited: 40
Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonresponders. Clinical colorectal cancer. 2006 Academic Article GET IT
Times cited: 17
Neuroendocrine tumors. Journal of the National Comprehensive Cancer Network : JNCCN. 2006 Conference Paper GET IT
Times cited: 9
Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 144
Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005 Academic Article GET IT
Times cited: 505
Antibody-based therapies for colorectal cancer. The oncologist. 2005 Review GET IT
Times cited: 43
Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2005 Academic Article GET IT
Times cited: 136
Cetuximab therapy and symptomatic hypomagnesemia. Journal of the National Cancer Institute. 2005 Review GET IT
Times cited: 210
Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer. International journal of radiation oncology, biology, physics. 2005 Academic Article GET IT
Times cited: 74
Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Review GET IT
Times cited: 452
Distal cT2N0 rectal cancer: is there an alternative to abdominoperineal resection?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 47
Metastatic colorectal cancer: is there one standard approach?. Oncology (Williston Park, N.Y.). 2005 Review GET IT
Times cited: 31
Anal canal cancer clinical practice guidelines in oncology. 2005 GET IT
Times cited: 10
Colon cancer clinical practice guidelines in oncology. 2005 GET IT
Times cited: 57
Rectal cancer clinical practice guidelines in oncology. 2005 GET IT
Times cited: 19
Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty service. Journal of the American College of Surgeons. 2005 Academic Article GET IT
Times cited: 68
Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 147
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Academic Article GET IT
Times cited: 100
HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum. The oncologist. 2005 Review GET IT
Times cited: 259
Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Annals of surgery. 2005 Academic Article GET IT
Times cited: 339
Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Academic Article GET IT
Times cited: 91
Occult primary cancer clinical practice guidelines. 2005 GET IT
Times cited: 2
ACCO: ASCO core curriculum outline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 33
Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 104
Is immunohistochemistry for epidermal growth factor receptor expression a poor predictor of response to epidermal growth factor receptor-targeted therapy?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Letter GET IT
Times cited: 13
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 1066
Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome. Annals of surgical oncology. 2004 Academic Article GET IT
Times cited: 21
Use of surgery among elderly patients with stage IV colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 194
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. Journal of the American College of Surgeons. 2004 Academic Article GET IT
Times cited: 181
Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Diseases of the colon and rectum. 2004 Academic Article GET IT
Times cited: 96
Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancer. Anti-cancer drugs. 2004 Academic Article GET IT
Times cited: 8
Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 1632
Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Diseases of the colon and rectum. 2004 Academic Article GET IT
Times cited: 229
Neuroendocrine carcinomas of the colon and rectum. Diseases of the colon and rectum. 2004 Academic Article GET IT
Times cited: 267
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for five days every three weeks to patients with metastatic adenocarcinoma of the colon or rectum. Investigational new drugs. 2004 Academic Article GET IT
Times cited: 12
Palliative management of rectal cancer: the roles of chemotherapy and radiation therapy. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2004 Academic Article GET IT
Times cited: 11
Irinotecan (Campto) in the treatment of pancreatic cancer. Expert review of anticancer therapy. 2003 Review GET IT
Times cited: 14
Update: colorectal cancer guidelines. Journal of the National Comprehensive Cancer Network : JNCCN. 2003 Academic Article GET IT
Times cited: 2
Another study of how to give fluorouracil?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Editorial Article GET IT
Times cited: 7
[Oxaliplatin: high activity at all stages of colon carcinomas]. Onkologie. 2003 Review GET IT
The camptothecins. Lancet (London, England). 2003 Review GET IT
Times cited: 354
Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Annals of surgical oncology. 2003 Academic Article GET IT
Times cited: 201
Anal canal cancer. Clinical practice guidelines in oncology. 2003 GET IT
Times cited: 3
Colon cancer. Clinical practice guidelines in oncology. 2003 GET IT
Times cited: 31
Rectal cancer. Clinical practice guidelines in oncology. 2003 GET IT
Times cited: 16
Understanding and managing chemotherapy-induced diarrhea. The journal of supportive oncology. 2003 Review GET IT
Times cited: 41
Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 227
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Annals of surgical oncology. 2002 Academic Article GET IT
Times cited: 58
Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 214
Adjuvant therapy of cancers of the colon and rectum. The Surgical clinics of North America. 2002 Review GET IT
Times cited: 47
Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2002 Academic Article GET IT
Times cited: 18
A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan. Annals of oncology : official journal of the European Society for Medical Oncology. 2002 Academic Article GET IT
Times cited: 97
Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Annals of surgery. 2002 Academic Article GET IT
Times cited: 250
Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 147
Safe and cost effective use of alteplase for the clearance of occluded central venous access devices. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 23
Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. Journal of the American College of Surgeons. 2002 Academic Article GET IT
Times cited: 315
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Academic Article GET IT
Times cited: 19
Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Annals of surgical oncology. 2001 Academic Article GET IT
Times cited: 109
Islet cell tumors of the pancreas: the medical oncologist's perspective. The Surgical clinics of North America. 2001 Review GET IT
Times cited: 134
Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 175
New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer. The Lancet. Oncology. 2001 Review GET IT
Times cited: 35
A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2001 Academic Article GET IT
Times cited: 41
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 201
Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. International journal of radiation oncology, biology, physics. 2001 Academic Article GET IT
Times cited: 151
A phase II study of irinotecan in patients with advanced hepatocellular carcinoma. Cancer. 2001 Academic Article GET IT
Times cited: 77
Abdominoperineal resection for rectal cancer at a specialty center. Diseases of the colon and rectum. 2001 Academic Article GET IT
Times cited: 103
Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard. The oncologist. 2001 Academic Article GET IT
Times cited: 126
Oral chemotherapy for colorectal cancer: some economic considerations. Oncology (Williston Park, N.Y.). 2001 Review GET IT
Times cited: 3
Perspectives on fluorinated pyrimidine use in gastrointestinal and breast oncology. Oncology (Williston Park, N.Y.). 2001 Review GET IT
Irinotecan-based combinations for the adjuvant treatment of stage III colon cancer. Oncology (Williston Park, N.Y.). 2000 Review GET IT
Times cited: 24
Postoperative radiation therapy for rectal cancer combined with UFT/leucovorin. Oncology (Williston Park, N.Y.). 2000 Academic Article GET IT
Times cited: 6
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. The New England journal of medicine. 2000 Academic Article GET IT
Times cited: 2878
High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer. International journal of radiation oncology, biology, physics. 2000 Academic Article GET IT
Times cited: 116
Anal cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000 Academic Article GET IT
Times cited: 1
Locally unresectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria. 2000 GET IT
Times cited: 3
Management of resectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000 Academic Article GET IT
Times cited: 5
Rectal cancer: presentation with metastatic and locally advanced disease. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000 Academic Article GET IT
Times cited: 2
MethyLight: a high-throughput assay to measure DNA methylation. Nucleic acids research. 2000 Academic Article GET IT
Times cited: 1221
Hepatic neuroendocrine metastases: does intervention alter outcomes?. Journal of the American College of Surgeons. 2000 Academic Article GET IT
Times cited: 533
Oral chemotherapeutic agents for colorectal cancer. The oncologist. 2000 Review GET IT
Times cited: 38
Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Diseases of the colon and rectum. 2000 Academic Article GET IT
Times cited: 155
Role of laparoscopy in the initial multimodality management of patients with near-obstructing rectal cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2000 Academic Article GET IT
Times cited: 26
Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Times cited: 248
Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma. Cancer. 1999 Academic Article GET IT
Times cited: 183
Conservative management of rectal cancer with local excision and postoperative adjuvant therapy. International journal of radiation oncology, biology, physics. 1999 Academic Article GET IT
Times cited: 67
CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer research. 1999 Academic Article GET IT
Times cited: 356
Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma. Cancer. 1999 Academic Article GET IT
Times cited: 13
Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Times cited: 350
A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesothelioma. Cancer investigation. 1999 Academic Article GET IT
Times cited: 25
The role of irinotecan in colorectal cancer. Current oncology reports. 1999 Review GET IT
Times cited: 7
Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 44
NCCN practice guidelines for occult primary tumors. National Comprehensive Cancer Network. 1998 GET IT
Times cited: 14
Irinotecan and cisplatin in upper gastrointestinal malignancies. Oncology (Williston Park, N.Y.). 1998 Review GET IT
Times cited: 18
Irinotecan in the first-line treatment of colorectal cancer. Oncology (Williston Park, N.Y.). 1998 Review GET IT
Times cited: 20
A phase II study of topotecan administered five times daily in patients with advanced gastric cancer. American journal of clinical oncology. 1997 Academic Article GET IT
Times cited: 15
9-Aminocamptothecin by 72-hour continuous intravenous infusion is inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma. Cancer. 1997 Academic Article GET IT
Times cited: 31
Adjuvant therapy of colorectal cancer. Surgical oncology clinics of North America. 1997 Review GET IT
Times cited: 10
Adjuvant therapy for colorectal cancer. Current problems in surgery. 1997 Review GET IT
Times cited: 28
Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Diseases of the colon and rectum. 1997 Academic Article GET IT
Times cited: 240
A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin. Clinical cancer research : an official journal of the American Association for Cancer Research. 1997 Academic Article GET IT
Times cited: 109
Phase I trial of PN401, an oral prodrug of uridine, to prevent toxicity from fluorouracil in patients with advanced cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Academic Article GET IT
Topotecan and the treatment of recurrent ovarian cancer: is there a role for granulocyte colony-stimulating factor?. Seminars in oncology. 1997 Review GET IT
Times cited: 4
Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. International journal of radiation oncology, biology, physics. 1997 Academic Article GET IT
Times cited: 159
Adjuvant treatment of colorectal cancer. Annual review of medicine. 1997 Review GET IT
Times cited: 18
Clinical Use of Irinotecan: Current Status and Future Considerations. The oncologist. 1997 Academic Article GET IT
A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescue. Cancer. 1996 Academic Article GET IT
Times cited: 8
Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 138
Influence of inflammatory bowel disease on the ability of patients to tolerate systemic fluorouracil-based chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 114
Irinotecan is an active agent in untreated patients with metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 318
Adjuvant Chemotherapy of Colorectal Cancer. The oncologist. 1996 Academic Article GET IT
CPT-11 (irinotecan) and 5-fluorouracil: a promising combination for therapy of colorectal cancer. European journal of cancer (Oxford, England : 1990). 1996 Review GET IT
Times cited: 46
Acute hypertensive crisis following octreotide administration in a patient with malignant pheochromocytoma. Oncology reports. 1995 Academic Article GET IT
A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma. Cancer. 1995 Academic Article GET IT
Times cited: 32
A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer. Cancer. 1995 Academic Article GET IT
Times cited: 102
Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer. Cancer. 1995 Academic Article GET IT
Times cited: 22
A phase I trial of intrahepatic verapamil and doxorubicin. Regional therapy to overcome multidrug resistance. Cancer. 1994 Academic Article GET IT
Times cited: 13
A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer. Cancer. 1994 Academic Article GET IT
Times cited: 33
A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors. Cancer. 1994 Academic Article GET IT
Times cited: 73
A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 171
Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer. 1994 Academic Article GET IT
Times cited: 128
Phase II trial of gemcitabine in patients with advanced gastric cancer. Cancer. 1994 Academic Article GET IT
Times cited: 28
Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor. Journal of the National Cancer Institute. 1993 Academic Article GET IT
Times cited: 140
A phase II trial of carboplatin in patients with advanced APUD tumors. Cancer. 1993 Academic Article GET IT
Times cited: 26
Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors. Cancer. 1993 Academic Article GET IT
Times cited: 269
The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer. 1993 Academic Article GET IT
Times cited: 107
Granulocyte colony-stimulating factor: effective in ameliorating fluorouracil-based myelosuppression?. Journal of the National Cancer Institute. 1993 Academic Article GET IT
Times cited: 6
Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. International journal of radiation oncology, biology, physics. 1993 Academic Article GET IT
Times cited: 59
Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1993 Academic Article GET IT
Times cited: 52
Combined-modality therapy in the treatment of local-regional esophageal cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 1992 Review GET IT
Times cited: 11
Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 186
Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 88
Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 41
Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Academic Article GET IT
Times cited: 232
Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer. International journal of radiation oncology, biology, physics. 1992 Academic Article GET IT
Times cited: 20
Drug treatment of colorectal cancer. Current status. Drugs. 1991 Review GET IT
Times cited: 10
Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer. Cancer. 1991 Academic Article GET IT
Times cited: 85
A phase I trial of cisplatin in hypertonic saline and escalating doses of 5-fluorouracil by continuous intravenous infusion in patients with advanced malignancies. Cancer. 1990 Academic Article GET IT
Times cited: 6
Angiocentric T-cell lymphoma associated with human T-cell lymphotropic virus type I infection. 1990 GET IT
Times cited: 20
Chemotherapy for large cell lymphoma: a status update. Seminars in oncology. 1990 Review GET IT
Times cited: 34
Augmentation by cytochalasin B of antigen receptor-mediated activation of normal and malignant human B lymphocytes. Scandinavian journal of immunology. 1990 Academic Article GET IT
Times cited: 1

more ...

less ...

Background

education and training

M.D., Yale University School of Medicine 1983
B.S., Stanford University 1979

Contact

full name

Leonard B. Saltz

VIVO Weill Cornell Medical College

Leonard B. Saltz Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name